PMID- 35944228
OWN - NLM
STAT- Publisher
LR  - 20240216
IS  - 2515-5091 (Electronic)
IS  - 2515-5091 (Linking)
VI  - 6
IP  - 4
DP  - 2022 Aug 9
TI  - Cancer Patient Acceptance of HIV Screening at a Large Tertiary Cancer Center.
LID - 10.1093/jncics/pkac055 [doi]
LID - pkac055
AB  - The U.S. Centers for Disease Control and Prevention (CDC), the U.S. Preventive 
      Services Task Force (USPSTF) and the National Comprehensive Cancer Network (NCCN) 
      recommend offering HIV testing for patients presenting for cancer care. Not 
      recognizing and treating HIV infection adversely impacts both cancer treatment 
      and HIV outcomes. Acceptance rates of oncology patients for HIV screening are not 
      known. Our tertiary cancer center inserted language requesting permission to 
      screen for HIV infection into the consent forms for initial presentation for 
      cancer care. Willingness to undergo testing was examined in 29,549 consecutive 
      new patients. These were analyzed by gender and age. Overall, 80.9% of patients 
      agreed to HIV screening. Incorporation of language requesting permission for HIV 
      screening into the consent form provided at presentation for cancer care, 
      relieves clinicians from adding this task.
CI  - (c) The Author(s) 2022. Published by Oxford University Press.
FAU - Granwehr, Bruno P
AU  - Granwehr BP
AD  - Department of Infectious Diseases, Division of Internal Medicine, The University 
      of Texas MD Anderson Cancer Center, Houston, Texas, USA.
FAU - Merriman, Kelly W
AU  - Merriman KW
AD  - Department of Tumor Registry, Division of Chief Quality Officer, The University 
      of Texas MD Anderson Cancer Center, Houston, Texas, USA.
FAU - Chiao, Elizabeth Y
AU  - Chiao EY
AD  - Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 
      Houston, Texas, USA.
AD  - Department of General Oncology, The University of Texas MD Anderson Cancer 
      Center, Houston, Texas, USA.
FAU - Grimes, Richard M
AU  - Grimes RM
AD  - Division of General Internal Medicine, Department of Internal Medicine, The 
      University of Texas Health Science Center at Houston, McGovern Medical School, 
      Houston, Texas, USA.
LA  - eng
PT  - Journal Article
DEP - 20220809
PL  - England
TA  - JNCI Cancer Spectr
JT  - JNCI cancer spectrum
JID - 101721827
SB  - IM
PMC - PMC9390220
EDAT- 2022/08/10 06:00
MHDA- 2022/08/10 06:00
PMCR- 2022/08/09
CRDT- 2022/08/09 16:03
PHST- 2021/11/05 00:00 [received]
PHST- 2022/05/20 00:00 [revised]
PHST- 2022/07/08 00:00 [accepted]
PHST- 2022/08/09 16:03 [entrez]
PHST- 2022/08/10 06:00 [pubmed]
PHST- 2022/08/10 06:00 [medline]
PHST- 2022/08/09 00:00 [pmc-release]
AID - 6659102 [pii]
AID - pkac055 [pii]
AID - 10.1093/jncics/pkac055 [doi]
PST - aheadofprint
SO  - JNCI Cancer Spectr. 2022 Aug 9;6(4):pkac055. doi: 10.1093/jncics/pkac055.